Ontology highlight
ABSTRACT: Background
Polycystic ovary syndrome (PCOS) is associated with cardiometabolic disease, but recent systematic reviews and meta-analyses of longitudinal studies that quantify these associations are lacking.Objective and rationale
Is PCOS a risk factor for cardiometabolic disease?Search methods
We searched from inception to September 2019 in MEDLINE and EMBASE using controlled terms (e.g. MESH) and text words for PCOS and cardiometabolic outcomes, including cardiovascular disease (CVD), stroke, myocardial infarction, hypertension (HT), type 2 diabetes (T2D), metabolic syndrome and dyslipidaemia. Cohort studies and case-control studies comparing the prevalence of T2D, HT, fatal or non-fatal CVD and/or lipid concentrations of total cholesterol (TC), low-density lipoprot
SUBMITTER: Wekker V
PROVIDER: S-EPMC7600286 | biostudies-literature | 2020 Nov
REPOSITORIES: biostudies-literature